Uncategorized
Imprimis reports $1.6 million in revenue in first quarter
Imprimis Pharmaceuticals reported total revenue of $1.6 million in the first quarter of 2015 compared with $2,000 in the first quarter of the previous year, according to a press release. Net loss was reported at $3.1 million, or $0.33 per common share, in the first quarter compared with a net loss of $2.3 million, or $0.26 per common share, in the first quarter of 2014.